Viking Therapeutics, Inc. (VKTX)
33.92
+2.04
(+6.40%)
USD |
NASDAQ |
Jan 16, 16:00
34.00
+0.08
(+0.24%)
Pre-Market: 20:00
Viking Therapeutics Cash from Discontinued Operations Adjustment (Quarterly)
Cash from Discontinued Operations Adjustment (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash from Discontinued Operations Adjustment (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Discontinued Operations Adjustment (Quarterly) Benchmarks
| Eli Lilly & Co. | -- |
| Pfizer Inc. | -- |
| Amgen, Inc. | -- |
| Altimmune, Inc. | -- |
| Moderna, Inc. | -- |